CytoMed Therapeutics GDTC
NASDAQ GDTC
$0.92 +0.02 (+2.22%)
At close: Oct 2, 2026 · 4:00 PM EDT

CytoMed Therapeutics (GDTC) Depreciation and Depletion (2023 - 2025)

Updated

CytoMed Therapeutics' Depreciation and Depletion was $283,995 in FY2025, up 17.8% from $241,175 in FY2024.

Analysis

CytoMed Therapeutics (GDTC) Depreciation and Depletion (2023 - 2025) Analysis & Trends

From FY2020 onward, CytoMed Therapeutics has reported Depreciation and Depletion for 6 years.

  • Depreciation and Depletion shows a five-year compound annual growth rate of 0.2% (FY2020 to FY2025).
  • The FY2025 figure marks the highest annual Depreciation and Depletion since FY2021.
  • Per Business Quant data, Depreciation and Depletion in earlier years was $241,175 in FY2024 (-13.6%), $279,120 in FY2023 (+1.3%), $275,494 in FY2022 (-13.0%) and $316,666 in FY2021 (+12.6%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 194.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 98.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 CytoMed Therapeutics 10.88 Mn -200,496.58 - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 84,490.00
Jun 30, 2024 120,399.00
Jun 30, 2023 146,758.00
API Access

CytoMed Therapeutics Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=GDTC&period=max&api_key=YOUR_API_KEY